272 related articles for article (PubMed ID: 31783779)
1. Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge 2018" (28-29 November, 2018, Naples, Italy).
Ascierto PA; Bifulco C; Buonaguro L; Emens LA; Ferris RL; Fox BA; Delgoffe GM; Galon J; Gridelli C; Merlano M; Nathan P; Odunsi K; Okada H; Paulos CM; Pignata S; Schalper KA; Spranger S; Tortora G; Zarour H; Butterfield LH; Puzanov I
J Immunother Cancer; 2019 Nov; 7(1):332. PubMed ID: 31783779
[TBL] [Abstract][Full Text] [Related]
2. Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy).
Ascierto PA; Brugarolas J; Buonaguro L; Butterfield LH; Carbone D; Daniele B; Ferris R; Fox BA; Galon J; Gridelli C; Kaufman HL; Klebanoff CA; Melero I; Nathan P; Paulos CM; Ruella M; Sullivan R; Zarour H; Puzanov I
J Immunother Cancer; 2018 Jul; 6(1):69. PubMed ID: 29996914
[TBL] [Abstract][Full Text] [Related]
3. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
[TBL] [Abstract][Full Text] [Related]
4. Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge" (December 4th-5th, 2019, Naples, Italy).
Ascierto PA; Butterfield LH; Campbell K; Daniele B; Dougan M; Emens LA; Formenti S; Janku F; Khleif SN; Kirchhoff T; Morabito A; Najjar Y; Nathan P; Odunsi K; Patnaik A; Paulos CM; Reinfeld BI; Skinner HD; Timmerman J; Puzanov I
J Transl Med; 2021 Jan; 19(1):13. PubMed ID: 33407605
[TBL] [Abstract][Full Text] [Related]
5. Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022).
Ascierto PA; Avallone A; Bifulco C; Bracarda S; Brody JD; Emens LA; Ferris RL; Formenti SC; Hamid O; Johnson DB; Kirchhoff T; Klebanoff CA; Lesinski GB; Monette A; Neyns B; Odunsi K; Paulos CM; Powell DJ; Rezvani K; Segal BH; Singh N; Sullivan RJ; Fox BA; Puzanov I
J Transl Med; 2023 Jul; 21(1):488. PubMed ID: 37475035
[TBL] [Abstract][Full Text] [Related]
6. Neoantigens in the immuno-oncology space.
Arlen PM
Future Oncol; 2017 Oct; 13(25):2209-2211. PubMed ID: 28976211
[No Abstract] [Full Text] [Related]
7. Immunomodulatory effects of current cancer treatment and the consequences for follow-up immunotherapeutics.
Mooradian MJ; Sullivan RJ
Future Oncol; 2017 Aug; 13(18):1649-1663. PubMed ID: 28776423
[TBL] [Abstract][Full Text] [Related]
8. Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021.
Ascierto PA; Avallone A; Bhardwaj N; Bifulco C; Bracarda S; Brody JD; Buonaguro L; Demaria S; Emens LA; Ferris RL; Galon J; Khleif SN; Klebanoff CA; Laskowski T; Melero I; Paulos CM; Pignata S; Ruella M; Svane IM; Taube JM; Fox BA; Hwu P; Puzanov I
J Transl Med; 2022 Jun; 20(1):257. PubMed ID: 35672823
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Checkpoints: Novel Avenues for Immunotherapy of Cancer.
Shevchenko I; Bazhin AV
Front Immunol; 2018; 9():1816. PubMed ID: 30131808
[TBL] [Abstract][Full Text] [Related]
10. Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy).
Ascierto PA; Agarwala SS; Botti G; Budillon A; Davies MA; Dummer R; Ernstoff M; Ferrone S; Formenti S; Gajewski TF; Garbe C; Hamid O; Lo RS; Luke JJ; Michielin O; Palmieri G; Zitvogel L; Marincola FM; Masucci G; Caracò C; Thurin M; Puzanov I
J Transl Med; 2019 Jul; 17(1):234. PubMed ID: 31331337
[TBL] [Abstract][Full Text] [Related]
11. Checkpoint blockade-based immunotherapy in the context of tumor microenvironment: Opportunities and challenges.
Duan J; Wang Y; Jiao S
Cancer Med; 2018 Sep; 7(9):4517-4529. PubMed ID: 30088347
[TBL] [Abstract][Full Text] [Related]
12. Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential?
Nixon AB; Schalper KA; Jacobs I; Potluri S; Wang IM; Fleener C
J Immunother Cancer; 2019 Nov; 7(1):325. PubMed ID: 31775882
[TBL] [Abstract][Full Text] [Related]
13. Role of cell surface proteoglycans in cancer immunotherapy.
Espinoza-Sánchez NA; Götte M
Semin Cancer Biol; 2020 May; 62():48-67. PubMed ID: 31336150
[TBL] [Abstract][Full Text] [Related]
14. Further Advances in Cancer Immunotherapy: Going Beyond Checkpoint Blockade.
Wilkinson RW; Leishman AJ
Front Immunol; 2018; 9():1082. PubMed ID: 29910800
[TBL] [Abstract][Full Text] [Related]
15. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
16. Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy).
Ascierto PA; Agarwala SS; Blank C; Caracò C; Carvajal RD; Ernstoff MS; Ferrone S; Fox BA; Gajewski TF; Garbe C; Grob JJ; Hamid O; Krogsgaard M; Lo RS; Lund AW; Madonna G; Michielin O; Neyns B; Osman I; Peters S; Poulikakos PI; Quezada SA; Reinfeld B; Zitvogel L; Puzanov I; Thurin M
J Transl Med; 2022 Sep; 20(1):391. PubMed ID: 36058945
[TBL] [Abstract][Full Text] [Related]
17. The importance for immunoregulation for long-term cancer control.
Fusi A; Dalgleish A
Future Oncol; 2017 Aug; 13(18):1619-1632. PubMed ID: 28776411
[TBL] [Abstract][Full Text] [Related]
18. Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies.
Patel SA; Minn AJ
Immunity; 2018 Mar; 48(3):417-433. PubMed ID: 29562193
[TBL] [Abstract][Full Text] [Related]
19. Cancer Cell-Intrinsic PD-1 and Implications in Combinatorial Immunotherapy.
Yao H; Wang H; Li C; Fang JY; Xu J
Front Immunol; 2018; 9():1774. PubMed ID: 30105035
[TBL] [Abstract][Full Text] [Related]
20. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]